Rexall Sundown
This article was originally published in The Tan Sheet
Executive Summary
Expects fiscal first quarter sales to be 11%-12% higher than the prior-year period but below expectations due to a "slow down in retail sales within the nutritional industry," the Boca Raton, Fla.-based dietary supplement marketer announces Nov. 5. Rexall says market data indicate the industry growth rate is 15% for the latest four-week period, down 3.7% "sequentially during a period where the company expected a sequential increase. This slower than expected growth rate precipitated many retailers to realign their inventory positions and ordering patterns which adversely impacted sales in the first quarter" (ending Dec. 31). "We now believe industry has returned to its historical mid-teens growth more quickly than expected," the company says. For the last fiscal year, Rexall sales increased 82% to $531 mil
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning